MedPath
FDA Approval

Cortrosyn

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Effective Date
November 13, 2021
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Tetracosactide(0.25 mg in 1 mL)

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Cortrosyn

Product Details

NDC Product Code
52584-050
Application Number
NDA016750
Marketing Category
NDA (C73594)
Route of Administration
PARENTERAL, INTRAVENOUS, INTRAMUSCULAR
Effective Date
July 11, 2017
Code: 72YY86EA29Class: ACTIBQuantity: 0.25 mg in 1 mL
© Copyright 2025. All Rights Reserved by MedPath